Background and Aims: Previous studies describing the cumulative failure rate after reconstructive surgery in patients with inflammatory bowel disease have been restricted to specific hospitals, and the generalizability of these results in a population-based setting is unknown. The aim of this study was to investigate the cumulative failure rate and risk factors for failure after reconstructive surgery in patients with inflammatory bowel disease. Methods: The study cohort includes all patients with inflammatory bowel disease in Sweden who underwent colectomy in 2000 through 2013 who were later treated with reconstructive surgery with ileal pouch-anal anastomosis or ileorectal anastomosis. Each patient was followed from admission for reconstructive surgery until admission for failure (a diverting stoma or permanent stoma), date of death, migration or December 31, 2013. Cumulative failure distributions were obtained with the Kaplan-Meier method, and multivariable Cox regression models were used to calculate the risk of failure. Results: Of the 1809 patients with inflammatory bowel disease treated with colectomy and reconstructive surgery, 83% had ulcerative colitis. During follow-up, 270 patients failed, and the cumulative failure rate was 4.1%, 13.2%, and 15.3% after 1, 3, and 5 years, respectively. The risk of failure was lower after treatment with ileal pouch-anal anastomosis than with ileorectal anastomosis [hazard ratio (95% confidence interval): 0.72 (0.56-0.93)]. Gender, hospital volume, and timing of reconstruction were not significantly associated with the risk of failure.
Introduction
Inflammatory bowel disease (IBD) is a chronic disease that often starts at a young age. 1, 2 Despite the evolution in medical therapies, 10-16% of patients with ulcerative colitis (UC) require surgical treatment with colectomy due to fulminant colitis, steroid-dependent disease, dysplasia, or cancer. 1, [3] [4] [5] The annual number of colectomies for IBD has remained unchanged in Sweden during the last 15 years. 6 In patients treated with colectomy in Sweden, only 45% of patients with UC and 35% of patients with CD received further treatment with reconstructive surgery with ileorectal anastomosis (IRA), ileal pouch-anal anastomosis (IPAA), or continent ileostomy, 7 and a significant risk factor for no reconstructive surgery was low hospital volume. Previously reported 5-year failure rates after reconstructive surgery have ranged between 2 and 26%, but these studies have been restricted to single, highly specialized centres, and no nationwide study has been published. [8] [9] [10] [11] The aim of this study was to investigate the cumulative failure rate of reconstructive surgery, i.e. IRA and IPAA, following subtotal colectomy or proctocolectomy, in a nationwide cohort of IBD patients. The hypothesis was that a high hospital volume was associated with success of reconstructive surgery.
Methods

Setting and cohort
This is a population-based cohort study based on data from Swedish nationwide registers. Since the Swedish health care service is publicly funded and available to all residents, and since unique personal identification numbers are assigned to all Swedish residents in Sweden 12 , all residents can be identified and followed through linkages to the virtually complete registers of hospitalizations, cancer, causes of death, and migration. 13, 14 Figure 1 describes the cohort. In the Swedish Patient Register, 4324 residents diagnosed with IBD (UC [the international classification of diseases, ninth revision (ICD-9): 556, ICD-10: K51] or CD [ICD-9: 555, ICD-10: K50]) in the Swedish Patient Register and treated with colectomy (surgical procedure code JFH) during the period January 1, 2000 to December 31, 2013 were identified. Of those, 2515 patients were excluded (not treated with reconstructive surgery or <15 years old), leaving 1809 patients in the study population.
The patients were either treated with IRA (surgical procedure codes JFH00, JFH01, JFC40, JFC41, JFG26, JFG29) or proctocolectomy with IPAA (surgical procedure codes JFH30, JFH33, JGB50, JGB60, JGB61) simultaneously with the colectomy (primary reconstruction) or during follow-up (secondary reconstruction).
In-patient data from the Swedish Patient Register from 1987 until the time of the hospitalization for the reconstructive surgery were used to categorize type of IBD. Patients were divided into three categories: (i) UC patients (records with UC only), (ii) CD patients (records with CD only), and (iii) neither of the above (patients only registered with an IBD diagnosis in out-patient care previous to the reconstructive surgery or given both UC and CD diagnoses at the time of reconstructive surgery).
Covariates
Age at reconstructive surgery was used to sort participants into five groups used to identify patients diagnosed with colorectal cancer prior to reconstructive surgery (ICD-7: 153 or 1540).
End point
Each patient was followed from the date of admission for reconstructive surgery without ileostomy. In the case of reconstructive surgery with ileostomy, the patient was followed from date of admission for closure of ileostomy. Failure was defined as new ileostomy, or permanent stoma (non-closure of the ileostomy for more than 2 years). The end point was the date of failure, death, emigration, or December 31, 2013, whichever came first. The end point of interest was failure, while death, emigration and end of follow-up were considered censoring events.
Statistical analysis
The cumulative failure distributions were estimated using the Kaplan-Meier method. Time to failure was tested between different patient categories using the log-rank test. The cumulative failure distribution (when death was considered as a competing event) was also estimated, and the curve was similar to the Kaplan-Meier curve. The Cox regression model was used to estimate crude and adjusted hazard ratios, with robust estimates for the standard errors. 15 The proportionality of the hazard functions across covariate patterns was visually inspected and tested with Schoenfeld's residuals. There was evidence of non-proportionality hazards between the different hospital volume categories, and therefore a stratified analysis was performed. The non-proportionality had no substantial effect on the estimated hazard ratios, and the non-stratified model was used in the final analyses. The multivariable model was adjusted for gender, age group, type of IBD, hospital volume, type of reconstruction (IRA or IPAA), timing (primary or secondary) and period of reconstructive surgery.
The analyses were carried out with Stata 14 (StataCorp, TX, USA). Statistical tests were 2-sided, and statistical significance was set at α = 0.05. Figure 1 shows that among the 1809 IBD patients treated with colectomy and reconstructive surgery in 2000 to 2013, 59.0% were treated with IRA and 41.0% with IPAA. A diverting stoma was used in 40.5% (9.1% in IRA patients and 86.0% in IPAA patients). During follow-up (mean 5.6 years, median 4.8 years, range 0-14.0 years), 270 failures occurred (192 received a new ileostomy and 78 received a permanent stoma), and 87 patients were censored (84 due to death and 3 due to emigration). Reconstructive surgery was performed in 59 hospitals. The number of hospitals in the volume categories varied. A total of 35-39 hospitals performed <5 reconstructions per year, 6-11 hospitals performed 5-11 reconstructions per year, and 1-2 hospitals performed ≥12 reconstructions per year.
Results
The patients' characteristics, including a separate column for patients with failed reconstruction, are presented in Table 1 . The majority were diagnosed with UC (1502), 219 were diagnosed with CD, and 88 were diagnosed with unspecified IBD. The median age at reconstructive surgery was 38 years (range 15-89). In about a half of the cases, the reconstruction was done after the colectomy (primary and secondary reconstruction were done in 818 and 991 patients, respectively). Although failures tended to occur more often in young patients (median age 36.5 years, range 16-76 years) the distribution was relatively even. Of those 163 patients diagnosed with colorectal cancer prior to reconstruction, failures were noted in 27 patients (16.6%).
The cumulative failure rates in the various subgroups are presented in Table 2 and in Figure 2 . Diverting ileostomies that were not closed after 2 years were considered as failures, explaining the drop at 2 years in Figure 2a -d. The cumulative failure rate was lower in older patients, and the 5-year cumulative failure rate in patients aged >54 years was 13.6%, compared with 19.2% in patients aged 15-24 years. The number was lower after reconstruction with IPAA compared with IRA (12.8% vs. 17.2%). Table 3 indicates the results of the multivariable Cox regression model were congruous with the above rates, showing a decreased risk in older age groups (hazard ratio [HR] 0.87; 95% confidence interval [CI] 0.80-0.96) for each 10-year increase in age) and a lower risk in patients treated with IPAA vs. IRA (HR 0.72; 95% CI 0.56-0.93). Gender, hospital volume, and timing of reconstruction were not significantly associated with cumulative failure rates or the risk of failure in the Cox regression model. Further stratification by timing of reconstruction and hospital volume showed similar results.
The descriptive statistics and cumulative failure rates in UC and CD patients were analysed separately, depending on type of surgery (Supplementary tables 1 and 2). In patients treated with IRA, the 1, 3, and 5-year cumulative failure rates were 5.2%, 15.8%, and 18.0% in 799 UC patients and 3.6%, 12.7%, and 14.9% in 199 CD patients. The corresponding numbers for IPAA were 3.3%, 10.7%, and 12.5% in 703 UC patients. In the multivariate analyses, there were no associations between failure and hospital volume in either group (Supplementary table 3 ). There were only 20 CD patients reconstructed with IPAA, of whom 1 (3.7%) failed.
In a sensitivity analysis, failure was only defined as new ileostomy (n = 192), and the corresponding cumulative failure rates were 4.4%, 8.1%, and 10.2% after 1, 3, and 5 years, respectively. As in the original analyses, the sensitivity analysis showed that the only factors associated with a decreased risk of failure were older age group (HR 0.85; 95% CI 0.77-0.95) and IPAA (HR 0.47; 95% CI 0.34-0.65).
Discussion
In this population-based study including all IBD patients reconstructed with IRA and IPAA following a colectomy in Sweden, the 5-year cumulative failure rate was 15.3%. The risk for failure was higher in the youngest age group and in patients treated with IRA. This is the largest study investigating the success rate of IRA in a cohort predominantly consisting of UC patients. In our study of 1068 patients treated with IRA, the 5-year cumulative failure rate was 17.2%. These results are similar to previously reported results: 16% at the Mayo Clinic, 16 19% at the Cleveland Clinic, 11 16% at a Finnish centre, 17 and 10.1% at a Swedish centre. 18 IRA is an option in UC patients with uninvolved or controlled rectum and no history of rectal dysplasia, but careful patient selection is crucial. Although an IRA is technically easier to perform than an IPAA, it is probable that choice of suitable patients for IRA improves with clinical experience. Even though hospital volume did not fall out as a predictor for failure, clinical inexperience might, at least somewhat, explain the discrepancy in failure rates between IRAs and IPAAs. Another explanation might be that IRA is used as a temporary solution in younger patients (with uninvolved, controlled, and non-dysplastic rectum) to avoid or at least to postpone pelvic surgery, 19, 20 and a higher failure rate is expected, at least in the long term.
To the best of our knowledge, this is the first nationwide population-based cohort study investigating the failure rate of IPAA in IBD patients. Previous studies have been restricted to high-volume centres, 8, 9, [18] [19] [20] or included reconstruction with IPAA in non-IBD patients. 21 The reported 5-year cumulative failure rate of 12.8% in patients treated with IPAA is higher than reported in previous studies mainly based on UC patients. Reported 5-year cumulative failure rates after IPAA were 3.6% at the Mayo Clinic, 20 4.1% at the Cleveland Clinic, 19 9% at St Marks, 9 5% at a Finnish centre, 8 and 6.1% at a Swedish centre. 18 The reason for the discrepancy between our nationwide results and previous experience is partially unknown, and probably not explained by differences in outcome measures. In addition to pouch excision or proctectomy/creation of an IPAA in IPAA and IRA patients, respectively, previous studies have used permanent stoma, 9,18,22 diverting ileostomy for more than one year, 10, 23 or long-term non-closure of the diverting ileostomy as the outcome measure. 19 Similarly, non-closure of the diverting ileostomy (within 2 years of the reconstructive procedure) was considered a failure in this study, and as a result there was a big drop in the survival curve after 2 years (Figure 2a-d) . Reconstructive surgery is performed in order to avoid a stoma, and if a defunctioning stoma is used, it is normally reversed within 6 months. To decrease the risk of overestimating the risk of failure, 2 years was chosen as the cut-off for failure.
In a previous report, a negative association between low hospital volume and the chance of reconstructive surgery was revealed, and our hypothesis was that hospital volume would also be associated with the success rate of reconstructive surgery. 7 However, despite the fact that no centralization of IBD surgery in Sweden has taken place and that reconstructive surgery in IBD patients was performed in as many as 59 hospitals during the studied period, there was no association between hospital volume and success rate. Since an annual volume of ≥12 reconstructions previously has been considered a high-volume centre, with better outcome in IPAA in general, 21 ≥12 was chosen as the cut-off for the highest category, even though only two hospitals or less reached that volume during any given year, and >75% of the hospitals were included in the lowest category. Most surgeons performing IPAA at low-volume units in Sweden today are previously trained at medium-or high-volume centres and thus are well experienced. This probably means that these procedures can be performed with acceptable quality today. Previous studies have shown the learning curve to be about 23 stapled IPAA why training a new surgeon at a centre performing only a handful a year must IBD diagnosis at the time of reconstruction. If the patients did not receive an IBD diagnosis at the admission, the earlier diagnosis was used. However, 88 patients did not receive an IBD diagnosis in inpatient care previous to the reconstructive surgery or were diagnosed with both ulcerative colitis and Crohn's disease at the admission for reconstructive surgery. They represent the category 'Unspecified'. The number of annual reconstructions with ileorectal anastomosis or ileal pouch anal anastomosis in IBD patients. IBD diagnosis at the time of reconstruction. If the patients did not receive an IBD diagnosis at the admission, the earlier diagnosis was used. However, 88 patients did not receive an IBD diagnosis in inpatient care previous to the reconstructive surgery or were diagnosed with both ulcerative colitis and Crohn's disease at the admission for reconstructive surgery. They represent the category 'Unspecified'. The number of annual reconstructions with ileorectal anastomosis or ileal pouch anal anastomosis in IBD patients. be considered very difficult; and may lead to impaired results in the future. 24 It is possible that patients with more severe colitis were referred to high-volume centres, but unfortunately clinical data, such as severity index, were not recorded in the registries. It should also be noted that the number of patients operated on in high-volume hospitals in our study could not be compared with centres like the Cleveland Clinic, which performed an average number of 232 IPAAs per year, 22 with 61% of the surgeries performed by only three surgeons. It would have been interesting to analyse the impact on failure rate from the individual surgeon's volume, since that factor might be of greater importance than hospital volume, 21 especially taking into consideration the training of new surgeons at referral centres. High-volume surgeons have been shown to perform two-stage IPAA to a greater extent than low-volume surgeons, 25 and with less risk of leaks and pouch-related sepsis. 26 In our material, there was no correlation between two-stage reconstructions and impaired outcome, and there was no difference between low-and high-volume units in the use of two-vs. three-stage procedures.
IPAA should only be performed in selected CD patients. The Cleveland Clinic performed IPAA in 150 CD patients and reported a 3-fold increased risk of pouch failure compared with UC patients. 22 Although based on small numbers (44 and 13 CD patients, respectively), previous studies have shown a 5-year failure rate of 24%, 20 and an overall failure rate of 46%. 9 Our results, based on only 20 CD patients, showed a 5-year cumulative failure rate of 7.7%. This somewhat strengthens the theory that reconstruction with an IPAA is feasible in highly selected CD patients.
As mentioned, a higher failure rate was observed in younger patients. The age-specific differences could be explained by indication for colectomy, since it is probable that dysplasia/cancer was more common in the oldest age group and fulminant colitis in the younger one. In addition, a higher success rate in the oldest patients could be explained by careful patient selection, since only 18.1% of patients ≥59 years treated with a colectomy were later reconstructed. 7 Strengths with the study include its national coverage, and that it is based on high-quality register data with complete follow-up and with low risk of information bias. Compared with single-centre studies, the results may be more generalizable to other countries where IBD surgery has not been centralized. However, despite the large size of the study, the risk of type II error cannot be excluded. As previously mentioned, one limitation is the lack of clinical data about the severity of colitis and medical treatment. There was no data on potential confounders such as postoperative complications, comorbidity, or other factors that may have influenced the risk of failure. In addition, the reasons for reconstruction failure were unknown. One could discuss whether deaths related to the pouch or ileorectal anastomosis should be considered failures. Since our information was restricted to register data, the patients were censored at the time of death, which could lead to an underestimation of the failure rate.
Conclusion
In conclusion, the 5-year cumulative failure rate in a nationwide setting was 15.3%, and the hospital volume was not associated with the risk of failure. IBD diagnosis at the time of reconstruction. If the patients did not receive an IBD diagnosis at the admission, the earlier diagnosis was used. However, 88 patients did not receive an IBD diagnosis in inpatient care previous to the reconstructive surgery or were diagnosed with both ulcerative colitis and Crohn's disease at the admission for reconstructive surgery. They represent the category 'Unspecified'. e The number of annual reconstructions with ileorectal anastomosis or ileal pouch anal anastomosis in IBD patients.
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